HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Robert J Harris Selected Research

Complementarity Determining Regions (Complementarity Determining Region)

1/2023B cell profiles, antibody repertoire and reactivity reveal dysregulated responses with autoimmune features in melanoma.
1/2021Tumor-Infiltrating B Lymphocyte Profiling Identifies IgG-Biased, Clonally Expanded Prognostic Phenotypes in Triple-Negative Breast Cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Robert J Harris Research Topics

Disease

21Neoplasms (Cancer)
01/2023 - 06/2005
12Glioblastoma (Glioblastoma Multiforme)
10/2018 - 01/2012
6Melanoma (Melanoma, Malignant)
01/2023 - 01/2019
6Glioma (Gliomas)
11/2018 - 08/2012
5BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
05/2015 - 10/2008
3Infections
01/2022 - 11/2017
3B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
10/2008 - 06/2005
2Brain Neoplasms (Brain Tumor)
11/2018 - 04/2013
2Persistent Infection
11/2017 - 10/2014
2Bacterial Infections (Bacterial Infection)
11/2017 - 10/2014
1Autoimmune Diseases (Autoimmune Disease)
01/2023
1Breast Neoplasms (Breast Cancer)
01/2021
1Virus Diseases (Viral Diseases)
01/2021
1Triple Negative Breast Neoplasms
01/2021
1Stroke (Strokes)
01/2019
1Ovarian Neoplasms (Ovarian Cancer)
01/2019
1Inflammation (Inflammations)
01/2019
1Ischemic Stroke
01/2019
1Epilepsy (Aura)
12/2015
1Tuberous Sclerosis (Bourneville's Disease)
12/2015
1Blast Crisis (Blast Phase)
06/2011
1Heart Failure
01/2011
1Mitochondrial Diseases (Mitochondrial Disease)
01/2011
1Hairy Cell Leukemia
02/2007
1Lymphadenopathy
06/2005

Drug/Important Bio-Agent (IBA)

5Bevacizumab (Avastin)FDA Link
10/2018 - 08/2012
3AntibodiesIBA
01/2023 - 01/2020
3AntigensIBA
01/2023 - 01/2019
3Biomarkers (Surrogate Marker)IBA
01/2020 - 08/2012
3AminesIBA
11/2018 - 11/2015
3Temozolomide (Temodar)FDA LinkGeneric
10/2018 - 09/2015
3Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
10/2017 - 06/2005
3Proteins (Proteins, Gene)FDA Link
07/2011 - 08/2006
2Complementarity Determining Regions (Complementarity Determining Region)IBA
01/2023 - 01/2021
2CytokinesIBA
01/2022 - 06/2005
2Protons (Proton)IBA
11/2018 - 11/2016
2MethyltransferasesIBA
10/2018 - 01/2012
2cabozantinibIBA
01/2018 - 01/2017
2Anti-Infective Agents (Microbicides)IBA
11/2017 - 10/2014
2Anti-Bacterial Agents (Antibiotics)IBA
11/2017 - 10/2014
2SilverIBA
11/2017 - 10/2014
2Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
05/2015 - 08/2006
2Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA
03/2014 - 05/2013
2Imatinib Mesylate (Gleevec)FDA Link
10/2009 - 10/2008
2ChemokinesIBA
10/2008 - 06/2005
1AutoantigensIBA
01/2023
1Galectins (Galectin)IBA
01/2022
1Folate Receptor 1IBA
01/2022
1RNA (Ribonucleic Acid)IBA
01/2022
1IpilimumabIBA
01/2021
1pembrolizumabIBA
01/2021
1NivolumabIBA
01/2021
1Immune Checkpoint ProteinsIBA
01/2021
1Monoclonal AntibodiesIBA
01/2021
1Antiviral Agents (Antivirals)IBA
01/2021
1Immunoglobulin A (IgA)IBA
01/2021
1Immunoglobulin D (IgD)IBA
01/2021
1Immunoglobulin G (IgG)IBA
01/2021
1Immunoglobulins (Immunoglobulin)IBA
01/2021
1Viral RNAIBA
01/2021
1Death Domain ReceptorsIBA
01/2021
1Neutralizing AntibodiesIBA
01/2021
1cyclopropapyrroloindoleIBA
01/2020
1Blocking AntibodiesIBA
01/2019
1ApolipoproteinsIBA
01/2019
1HaptoglobinsIBA
01/2019
1Immune Checkpoint InhibitorsIBA
01/2019
1Oxygen (Dioxygen)IBA
11/2018
1Proto-Oncogene Proteins c-metIBA
01/2018
1Tyrosine Kinase InhibitorsIBA
01/2018
1Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA
01/2018
1Lomustine (CCNU)FDA Link
10/2017
1paclitaxel poliglumex (XYOTAX)IBA
06/2017
1trans-sodium crocetinate (crocetin)IBA
12/2015
1Lactic Acid (Lactate)FDA LinkGeneric
11/2015
1Leukotriene B4 Receptors (Leukotriene B4 Receptor)IBA
11/2014
1Contrast MediaIBA
04/2014
1alovudineIBA
08/2012
1fluorodopa F 18IBA
08/2012
1O-(6)-methylguanineIBA
01/2012
1DNA (Deoxyribonucleic Acid)IBA
01/2012
1Phosphoric Monoester Hydrolases (Phosphatases)IBA
06/2011
1Fatty Acids (Saturated Fatty Acids)IBA
01/2011
1LipidsIBA
01/2011
1Organic Cation Transporter 1IBA
10/2008
1Dasatinib (BMS 354825)FDA Link
10/2008
1Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA
02/2007
1Protein Kinases (Protein Kinase)IBA
02/2007
1IntegrinsIBA
06/2005
1Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA
06/2005
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
06/2005

Therapy/Procedure

8Therapeutics
01/2021 - 04/2013
3Chemoradiotherapy
11/2015 - 03/2014
2Immunotherapy
01/2021 - 01/2020
2Aftercare (After-Treatment)
05/2015 - 11/2014
1Drug Therapy (Chemotherapy)
01/2021
1Radiotherapy
09/2015